| Autor: | Christian von Heymann, Wolfgang Konertz, Marc Kastrup, Maryam Moshirzadeh, Dominik Jasulaitis, Jan-Peter Braun, Pascal M. Dohmen, Claudia Spies, Ulrich R. Doepfmer |
|---|---|
| Rok vydání: | 2006 |
| Předmět: |
Inotrope
medicine.medical_specialty business.industry medicine.medical_treatment Retrospective cohort study macromolecular substances Levosimendan Critical Care and Intensive Care Medicine medicine.disease Internal medicine Heart failure Hospital discharge Cardiology Medicine In patient business Cardiotomy Survival rate medicine.drug |
| Zdroj: | Critical Care. 10:R17 |
| ISSN: | 1364-8535 |
| DOI: | 10.1186/cc3979 |
| Popis: | Introduction Most case series suggest that less than half of the patients receiving a mechanical cardiac assist device as a bridge to recovery due to severe post-cardiotomy heart failure survive to hospital discharge. Levosimendan is the only inotropic substance known to improve medium term survival in patients suffering from severe heart failure. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink